Catalyst Wire Dossier Catalyst Wire Dossier

SYN111

rufinamide · Biotie Therapies Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYN111, covering 2019-01-23 to 2019-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD) [Phase 2]

See pricing